Li et al., 1995 - Google Patents
Potential Role of WAF1/Cip1/p21 as a Mediator of TGF-β Cytoinhibitory Effect (∗)Li et al., 1995
View HTML- Document ID
- 15219148471550902698
- Author
- Li C
- Suardet L
- Little J
- Publication year
- Publication venue
- Journal of Biological Chemistry
External Links
Snippet
Transforming growth factor-β (TGF-β) inhibits cell cycle progression of many types of human cells by arresting them in the G 1 phase of the cell cycle. The arrest is mediated through interactions of various cyclin-dependent protein kinases (CDKs) and their inhibitors. We …
- 101710022308 CDKN1A 0 title abstract description 51
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Li et al. | Potential Role of WAF1/Cip1/p21 as a Mediator of TGF-β Cytoinhibitory Effect (∗) | |
| Huang et al. | p38 kinase mediates UV-induced phosphorylation of p53 protein at serine 389 | |
| De Luca et al. | A unique domain of pRb2/p130 acts as an inhibitor of Cdk2 kinase activity | |
| Li et al. | The human Cdc14 phosphatases interact with and dephosphorylate the tumor suppressor protein p53 | |
| Rössig et al. | Glycogen synthase kinase-3 couples AKT-dependent signaling to the regulation of p21Cip1 degradation | |
| Chini et al. | Human claspin is required for replication checkpoint control | |
| Castro et al. | Rheb binds tuberous sclerosis complex 2 (TSC2) and promotes S6 kinase activation in a rapamycin-and farnesylation-dependent manner | |
| Leggett et al. | Sp1 Is Phosphorylated and Its DNA Binding Activity Down-regulated upon Terminal Differentiation of the Liver (∗) | |
| Aprelikova et al. | Both p16 and p21 families of cyclin-dependent kinase (CDK) inhibitors block the phosphorylation of cyclin-dependent kinases by the CDK-activating kinase | |
| Cortez et al. | Minichromosome maintenance proteins are direct targets of the ATM and ATR checkpoint kinases | |
| Altschuler et al. | Cyclic AMP-dependent activation of Rap1b | |
| Connell-Crowley et al. | G1 cyclin-dependent kinases are sufficient to initiate DNA synthesis in quiescent human fibroblasts | |
| Zhong et al. | The transcriptional activity of NF-κB is regulated by the IκB-associated PKAc subunit through a cyclic AMP–independent mechanism | |
| Zhang et al. | Small-molecule synergist of the Wnt/β-catenin signaling pathway | |
| Yang et al. | EWS· Fli-1 fusion protein interacts with hyperphosphorylated RNA polymerase II and interferes with serine-arginine protein-mediated RNA splicing | |
| Yannone et al. | Werner syndrome protein is regulated and phosphorylated by DNA-dependent protein kinase | |
| Soga et al. | Radicicol leads to selective depletion of Raf kinase and disrupts K-Ras-activated aberrant signaling pathway | |
| Guo et al. | Inhibition of myogenesis by multiple cyclin-Cdk complexes: coordinate regulation of myogenesis and cell cycle activity at the level of E2F | |
| Kato et al. | Inactivation of the cyclin D-dependent kinase in the rat fibroblast cell line, 3Y1, induced by contact inhibition | |
| Wei et al. | Phosphorylation of minichromosome maintenance protein 7 (MCM7) by cyclin/cyclin-dependent kinase affects its function in cell cycle regulation | |
| Urano et al. | p57Kip2 is degraded through the proteasome in osteoblasts stimulated to proliferation by transforming growth factor β1 | |
| Winston et al. | Differential Modulation of G1 Cyclins and the Cdk Inhibitor p27kip1 by Platelet-derived Growth Factor and Plasma Factors in Density-arrested Fibroblasts (∗) | |
| Peschiaroli et al. | The F-box protein FBXO45 promotes the proteasome-dependent degradation of p73 | |
| Carter et al. | Persistent activation of NF-κB by the tax transforming protein involves chronic phosphorylation of IκB kinase subunits IKKβ and IKKγ | |
| Wiederschain et al. | Multiple mixed lineage leukemia (MLL) fusion proteins suppress p53-mediated response to DNA damage |